New research suggests GLP-1 medications can blunt people's cravings for potentially addictive substances like opioids.

A recent study suggests that semaglutide, typically used for Type 2 diabetes, may significantly reduce the risk of opioid overdoses in patients with opioid use disorder, according to research ...

In times of personal crisis, Catholics often turn to their parish priest for help. But in the Archdiocese of Newark, the ...

Although the new findings are "unclear," researchers are curious to see if appetite suppressants could be used for addiction treatment. A separate study found that fentanyl users trying to kick the ...

The active ingredient in the popular diabetes and obesity drugs Ozempic and Wegovy could be linked to a drop in opioid ...